Baker Avenue Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Baker Avenue Asset Management's LLY Position: Q1 2026 in Review
Baker Avenue Asset Management increased its Eli Lilly (LLY) stake by 21% in Q1 2026, buying an estimated $4.57M and bringing the position to 25,996 shares worth $23.9M. The position accounts for 0.54% of the portfolio, ranked #43.
Baker Avenue Asset Management first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Baker Avenue Asset Management held 25,996 shares of Eli Lilly worth $23.9M as of Q1 2026.
- Baker Avenue Asset Management bought 4,508 Eli Lilly shares in Q1 2026, an estimated $4.57M.
- Eli Lilly made up 0.54% of Baker Avenue Asset Management's portfolio in Q1 2026, its #43 holding.
- Baker Avenue Asset Management first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Baker Avenue Asset Management's 13F filing for Q1 2026, filed 12 May 2026.